Candida albicans phospholipomannan is sensed through toll-like receptors

Journal of Infectious Diseases

Volumn 188, Issue 1, 2003, Pages 165-172

  Jouault, Thierry ^a,c   Ibata Ombetta, Stella ^a   Takeuchi, Osamu ^b   Trinel, Pierre André ^a   Sacchetti, Paola ^a   Lefebvre, Philippe ^a   Akira, Shizuo ^b   Poulain, Daniel ^a  

^a INSERM   (France)

^b OSAKA UNIVERSITY   (Japan)

^c UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOLIPID; PHOSPHOLIPOMANNAN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE DELETION; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; CANDIDA ALBICANS; CELL LINE; FEMALE; GLYCOLIPIDS; HUMANS; MACROPHAGES, PERITONEAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; NF-KAPPA B; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037560071     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/375784     Document Type: Article

References (50)

1. Calderone R. Candida and candidiasis. Washington, DC: American Society of Microbiology Press, 2002.
2. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic. Diagn Microbiol Infect Dis 1998; 30:121-9.
3. Romani L. Innate and adaptive immunity in Candida albicans infections and saprophytism. J Leukoc Biol 2000;68:175-9.
4. Domer J, Elkins K, Ennist D, Baker P. Modulation of immune responses by surface polysaccharides of Candida albicans. Rev Infect Dis 1988; 10(Suppl 2):S419-22.
5. Cassone A, Marconi P, Bistoni F. Cell wall of Candida albicans and host response. Crit Rev Microbiol 1987; 15:87-95.
6. Szabo I, Guan L, Rogers TJ. Modulation of macrophage phagocytic activity by cell wall components of Candida albicans. Cell Immunol 1995; 164:182-8.
7. Jouault T, Lepage G, Bernigaud A, et al. β-1,2-linked oligomannosides from Candida albicans act as signals for tumor necrosis factor α production. Infect Immun 1995;63:2378-81.
8. Jouault T, Fradin C, Trinel PA, Poulain D. Candida albicans-derived β-1,2-linked mannooligosaccharides induce desensitization of macrophages. Infect Immun 2000;68:965-8.
9. Rotstein D, Parodo J, Taneja R, Marshall JC. Phagocytosis of Candida albicans induces apoptosis of human neutrophils. Shock 2000; 14:278-83.
10. Ibata-Ombetta S, Jouault T, Trinel PA, Poulain D. Role of extracellular signal-regulated protein kinase cascade in macrophage killing of Candida albicans. J Leukoc Biol 2001; 70:149-54.
11. Trinel P, Jouault T, Cutler J, Poulain D. β-1,2 mannosylation of Candida albicans mannoproteins and glycolipids differs with growth temperature and serotype. Infect Immun 2002; 70:5274-8.
12. Poulain D, Slomianny C, Jouault T, Gomez J, Trinel P. Contribution of the phospholipomannan to surface expression of β-1,2 oligomannosides in Candida albicans and its presence in cell wall extracts. Infect Immun 2002; 70:4323-8
13. Trinel PA, Borg-von-Zepelin M, Lepage G, Jouault T, Mackenzie D, Poulain D. Isolation and preliminary characterization of the 14- to 18-kilodalton Candida albicans antigen as a phospholipomannan containing β-1,-2-linked oligomannosides. Infect Immun 1993;61:4398-405.
14. Jouault T, Bernigaud A, Lepage G, Trinel PA, Poulain D. The Candida albicans phospholipomannan induces in vitro production of tumour necrosis factor-α from human and murine macrophages. Immunology 1994; 83:268-73.
15. Jouault T, Fradin C, Trinel PA, Bernigaud A, Poulain D. Early signal transduction induced by Candida albicans in macrophages through shedding of a glycolipid. J Infect Dis 1998; 178:792-802.
16. Trinel PA, Maes E, Zanetta JP, et al. Candida albicans phospholipomannan, a new member of the fungal mannoseinositolphosphoceramide family. J Biol Chem 2002; 277:37260-71.
17. Lien E, Ingalls RR. Toll-like receptors. Crit Care Med 2002; 30:S1-11.
18. Underhill DM, Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol 2002; 14:103-10.
19. Takeuchi O, Kawai T, Muhlradt PF, et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 2001; 13:933-40.
20. Takeda K, Akira S. Roles of Toll-like receptors in innate immune responses. Genes Cells 2001;6:733-42.
21. Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999; 11:443-51.
22. Hoshino K, Takeuchi O, Kawai T, et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product. J Immunol 1999; 162:3749-52.
23. Hirschfeld M, Kirschning CJ, Schwandner R, et al. Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by Toll-like receptor 2. J Immunol 1999; 163:2382-6.
24. Dziarski R, Wang Q, Miyake K, Kirschning CJ, Gupta D. MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to gram-positive and gram-negative bacteria and their cell wall components. J Immunol 2001; 166:1938-44.
25. Underhill DM, Ozinsky A, Hajjar AM, et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999; 401:811-5.
26. Netea M, Van der Graaf C, Vonk A, Verschueren I, Van der Meer J, Kullberg B. The role of Toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J Infect Dis 2002; 185:1483-9.
27. Trinel PA, Plancke Y, Gerold P, et al. The Candida albicans phospholipomannan is a family of glycolipids presenting phosphoinositolmannosides with long linear chains of β-1,2-linked mannose residues. J Biol Chem 1999;274:30520-6.
28. Lin Y, Lee H, Berg AH, Lisanti MP, Shapiro L, Scherer PE. The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J Biol Chem 2000; 275:24255-63.
29. Yang S, Sugawara S, Monodane T, et al. Micrococcus luteus teichuronic acids activate human and murine monocytic cells in a CD14- and Toll-like receptor 4-dependent manner. Infect Immun 2001;69:2025-30.
30. Baeuerle PA, Baltimore D. NF-κB: ten years after. Cell 1996;87:13-20.
31. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001; 13:85-94.
32. Cutler JE. N-glycosylation of yeast, with emphasis on Candida albicans. Med Mycol 2001; 39(Suppl 1):75-86.
33. Stahl P. The macrophage mannose receptor: current status. Am J Respir Cell Mol Biol 1990;2:317-8.
34. Torosantucci A, Chiani P, Cassone A. Differential chemokine response of human monocytes to yeast and hyphal forms of Candida albicans and its relation to the β-1,6 glucan of the fungal cell wall. J Leukoc Biol 2000; 68:923-32.
35. Brown GD, Gordon S. Immune recognition. A new receptor for β-glucans. Nature 2001;413:36-7.
36. Suzuki S. Immunochemical study on mannans of genus Candida. I. Structural investigation of antigenic factors 1, 4, 5, 6, 8, 9, 11, 13, 13b and 34. Curr Top Med Mycol 1997;8:57-70.
37. Fradin C, Poulain D, Jouault T. β-1,2-linked oligomannosides from Candida albicans bind to a 32-kilodalton macrophage membrane protein homologous to the mammalian lectin galectin-3. Infect Immun 2000; 68:4391-8.
38. O'Neill LA. Signal transduction pathways activated by the IL-1 receptor/Toll-like receptor superfamily. Curr Top Microbiol Immunol 2002; 270:47-61.
39. Flo TH, Halaas O, Torp S, et al. Differential expression of Toll-like receptor 2 in human cells. J Leukoc Biol 2001; 69:474-81.
40. Underhill DM, Ozinsky A, Smith KD, Aderem A. Toll-like receptor-2 mediates Mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci USA 1999;96:14459-63.
41. Opitz B, Schroder NW, Spreitzer I, et al. Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-κB translocation. J Biol Chem 2001; 276:22041-7.
42. Campos MA, Almeida IC, Takeuchi O, et al. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J Immunol 2001; 167:416-23.
43. Kirschning CJ, Schumann RR. TLR2: cellular sensor for microbial and endogenous molecular patterns. Curr Top Microbiol Immunol 2002; 270:121-44.
44. Takeuchi O, Sato S, Horiuchi T, et al. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002; 169:10-4.
45. Flo TH, Ryan L, Latz E, et al. Involvement of Toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers. J Biol Chem 2002; 277:35489-95.
46. Sorenson WG, Shahan T, Simpson J. Cell wall preparations from environmental yeasts: effect on alveolar macrophage function in vitro. Ann Agric Environ Med 1998; 5:65-71.
47. Fradin C, Jouault T, Mallet A, et al. β-1,2-linked oligomannosides inhibit Candida albicans binding to murine macrophage. J Leukoc Biol 1996; 60:81-7.
48. Ozinsky A, Underhill DM, Fontenot JD, et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc Natl Acad Sci USA 2000; 97:13766-71.
49. Nitz M, Ling CC, Otter A, Cutler JE, Bundle DR. The unique solution structure and immunochemistry of the Candida albicans β-1,2-mannopyranan cell wall antigens. J Biol Chem 2002; 277:3440-6.
50. Akashi S, Nagai Y, Ogata H, et al. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int Immunol 2001; 13:1595-9.